Breaks Categories: News

ThursdayMar 07, 2024 1:53 pm

NetworkNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Awarded Two New US Patents Covering Core Cardiac Monitoring Technology

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, has received notification that two of its patents covering core vectorelectrocardiography (“VECG”) have been awarded by the United States Patent and Trademark Office. The two new patents bring the total of issued patents in HeartBeam’s portfolio to 14, with four international patents as well; the company also has 20 pending patent applications worldwide. HeartBeam’s VECG technology collects 3D signals of the heart and converts them into a 12-lead ECG. The first awarded patent, “Mobile three-lead cardiac monitoring device and method for automated…

Continue Reading

ThursdayMar 07, 2024 1:29 pm

NetworkNewsBreaks — SOBR Safe Inc. (NASDAQ: SOBR) Announces New Customer in Sober Living Space

SOBRSafe (NASDAQ: SOBR), providers of next-generation transdermal alcohol detection solutions, has announced a new customer: Breyta House, a sober-living facility located in Houston. The facility empowers women on their journey to recovery and overall wellness. Bretya House will initially be installing SOBRcheck(TM) for point-of-care alcohol screening. Sober-living facilities, or recovery housing, is a recovery support service specifically for those working to recover from substance-use issues. According to the announcement, there are currently an estimated 17,934 recovery homes located in the United States. “With our ability to provide both point-of-care screening and continuous monitoring, we believe that we are uniquely positioned to support…

Continue Reading

ThursdayMar 07, 2024 1:12 pm

NetworkNewsBreaks – Clene Inc. (NASDAQ: CLNN) Announces Participation at Upcoming 36th Annual Roth Conference

Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company, and its wholly owned subsidiary Clene Nanomedicine Inc., will be represented at this month’s annual Roth Conference. The conference will be held March 18–19, 2024, in Dana Point, California. According to the announcement, company officials are scheduled to present a fireside chat, slated to begin at 8 a.m. PST on March 18, 2024. Clene focuses on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”). An archived version of the presentation will be available following the webcast on the company website.…

Continue Reading

WednesdayMar 06, 2024 1:41 pm

NetworkNewsBreaks — Good Gaming Inc. (GMER) Newest Release Announced as Primary Sponsor in NASCAR’s 2024 ARCA Menards Race Series

Good Gaming (OTCQB: GMER), an innovative brand creating unique interactive entertainment experiences across the gaming segment since 2008, and its first mobile game release, Galactic Acres(TM), will be the primary sponsor for the #73 car in the upcoming General Tire 150 part of NASCAR's ARCA Menards race series. According to the announcement, Galactic Acres will join forces with driver and fan favorite Andy Jankowiak for the event, which will be held March 8, 2024, in Phoenix. Launched last month, Galactic Acres, which is the first in a series of mobile games enhanced with Web3 technology, represents a groundbreaking fusion of…

Continue Reading

WednesdayMar 06, 2024 1:35 pm

NetworkNewsBreaks – Software Effective Solutions Corp. (SFWJ) Expands Portfolio, Marking Major Step Toward World-Leading Integration

Software Effective Solutions (OTC: SFWJ) (d/b/a MedCana) today announced the successful acquisition of two additional companies, expanding its portfolio to nine innovative enterprises. According to the announcement, the strategic expansion includes a company with a critical cannabis genetics license and another with comprehensive licenses to produce, process and export cannabis products. “These acquisitions represent a monumental step towards our vision of becoming a world-leading integrated cannabis company,” said Jose Gabriel Diaz, CEO of MedCana. “With seven cannabis producing companies, one agriculture technology and infrastructure company, and one software company under our belt, MedCana is exceptionally positioned to innovate, produce and…

Continue Reading

WednesdayMar 06, 2024 1:20 pm

NetworkNewsBreaks — D-Wave Quantum Inc. (NYSE: QBTS) Unveils GTM Growth Strategy to Increase Adoption and Deployment of Quantum Technologies

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services and the world’s first commercial supplier of quantum computers, announced a new go-to-market (“GTM”) growth strategy designed to accelerate adoption and deployment of commercial quantum technologies. According to the announcement, the strategy, which is focused on key verticals including logistics, manufacturing and government, extends D-Wave’s leadership position in commercial quantum computing and helps organizations solve their most computationally complex problems today. The company has also unveiled a logistics-focused campaign to support the new GTM effort. The campaign includes a new e-book titled “Moving Forward: How Quantum-Powered Logistics…

Continue Reading

TuesdayMar 05, 2024 3:41 pm

NetworkNewsBreaks – Mushrooms Inc. (MSRM) Announces Latest Product Launches, Development Collaboration in Germany

Mushrooms (OTC: MSRM), a developing leader in biotechnology and sustainable healthcare innovation using mushrooms and mycelium, today announced a suite of strategic initiatives aimed at transforming the healthcare landscape. These efforts, which underscore Mushrooms Inc.’s commitment to innovation, sustainability and the advancement of global health, include the launch of two groundbreaking health supplements, LONGEVITY and SPORT+, as well as the exploration of a development collaboration with a renowned scientific team in Germany. “We are at an exciting juncture in our journey,” said Mushrooms Inc. CEO Kimberly Carlson. “Our latest product launches and the collaboration in Germany are pivotal steps towards…

Continue Reading

TuesdayMar 05, 2024 3:36 pm

NetworkNewsBreaks — SenesTech Inc. (NASDAQ: SNES) Announces Participation at Tomorrow’s Emerging Growth Conference

SenesTech (NASDAQ: SNES), the rodent-fertility control experts and inventors of ContraPest(R), the only EPA-registered contraceptive for male and female rats, will be presenting at the Emerging Growth Conference, which is scheduled for March 6, 2024. According to the announcement, key company leaders will deliver a webcast presentation; the presentation will include time for a Q&A. The presentation is slated to begin at 1:10 p.m. ET. An archived replay of the presentation will be available on the Emerging Growth YouTube channel following the webcast. In addition, SenesTech representatives will be available for one-on-one investor meetings. To view the presentation, visit https://nnw.fm/Bz6bz…

Continue Reading

TuesdayMar 05, 2024 3:23 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) to Commence Diabetes and Weight Loss Animal Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced details for an eight-week animal study, WEIGHT-A24-1, to examine diabetes and weight loss effects of DehydraTECH-processed glucagon-like peptide 1 (“GLP-1”) drugs and DehydraTECH-processed cannabidiol, alone and in combination. The contract for the study was awarded to a third-party, Health Canada-licensed research laboratory. Manufacturing of the compositions for the first eight of the 12 study arms has been completed, and those arms will commence as soon as possible at the testing laboratory, expected to begin within 45 days. Each arm of the study will be dosed for…

Continue Reading

TuesdayMar 05, 2024 3:10 pm

NetworkNewsBreaks – Sigyn Therapeutics Inc. (SIGY) Announces CEO Presentation at Upcoming Emerging Growth Conference

Sigyn Therapeutics (OTCQB: SIGY), a development-stage medical technology company, will be participating at tomorrow’s Emerging Growth Conference. The company announced that CEO Jim Joyce will give a live presentation; the presentation is slated to begin at 12 p.m. ET. According to the announcement, Joyce will provide an update on Sigyn Therapy(TM), the company’s novel blood-purification technology designed to address life-threatening conditions that are beyond the reach of drugs, and will review the company’s candidate products designed to enhance the benefit of chemotherapy and immunotherapeutic antibodies to treat cancer. The presentation will also include time for a Q&A. An archived copy…

Continue Reading